ITEMS IN AFP WITH KEYWORD:
Incontinence, Overactive Bladder
Structured PFMT beginning early in pregnancy prevents the onset of urge incontinence later in pregnancy and in the postpartum period compared with no intervention. There is no evidence that PFMT improves urinary incontinence later in pregnancy or in the postpartum period in pregnant patients who alr...
Apr 1, 2020 Issue
Pelvic Floor Muscle Training vs. Control for Urinary Incontinence in Women [Cochrane for Clinicians]
Use of pelvic floor muscle training to treat women with all subtypes of urinary incontinence results in improvement or cure vs. no treatment (number needed to treat [NNT] = 2.5; 95% CI, 1.4 to 5.4). Treatment with pelvic floor muscle training also results in one fewer episode of leakage per day and ...
Feb 1, 2018 Issue
OnabotulinumtoxinA Injections for Urge Incontinence [FPIN's Help Desk Answers]
Detrusor muscle injections of onabotulinumtoxinA can be used to decrease the number of episodes of urinary incontinence in women for whom treatment with anticholinergic agents has been ineffective.
The American College of Physicians (ACP) has provided recommendations for nonsurgical treatment of UI in women. Treatment of UI is aimed at achieving, or at least improving, symptoms. It is deemed effective if it reduces the number of episodes by at least one-half.
This intervention, which included primiparous women with and without urinary incontinence at six weeks post-partum, demonstrated that intensive supervised pelvic floor muscle training did not reduce the prevalence of urinary incontinence at six months. These results are noteworthy because the trial was well designed and the results were unexpected.
Jun 1, 2013 Issue
AUA Releases Guideline on Diagnosis and Treatment of Overactive Bladder [Practice Guidelines]
Overactive bladder is characterized by urinary symptoms including urgency, frequency, and nocturia, with or without urge incontinence. The American Urological Association (AUA) recently published recommendations to provide a clinical framework for the diagnosis and treatment of non-neurogenic overactive bladder.
What are the effectiveness, benefits, and adverse effects of options for diagnosis and treatment of urinary incontinence (UI) that are available in primary care?
Most cases of urinary incontinence in women fall under one of three major subtypes: urge, stress, or mixed. A stepped-care approach that advances from least invasive (behavioral modification) to more invasive (surgery) interventions is recommended. Bladder retraining and pelvic floor muscle exercise...
Urinary incontinence is common, increases in prevalence with age, and affects quality of life for men and women. The initial evaluation occurs in the family physician’s office and generally does not require urologic or gynecologic evaluation. The basic workup is aimed at identifying possible reversi...
Jul 1, 2011 Issue
Hormone Therapy for Postmenopausal Women with Urinary Incontinence [FPIN's Clinical Inquiries]
Postmenopausal women should not receive oral hormone therapy for treatment of urinary incontinence.